Delivery Order SPE2DX22D0039-SPE2D826F0DP5
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $8,771.85 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The work...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $34,835.16 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price, non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract is performed at...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,144.41 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract under a larger indefinite delivery vehicle and was competitively awarded without set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $4,146.72 on January 6, 2026, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price, non-set-aside contract represents a child task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026. The place of performance is Conshohocken, Pennsylvania, with...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,109.36 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was not set-aside and was competitively awarded. The contract represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,287.20 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract represents a child award under Amerisourcebergen's parent company Cencora, Inc. and carries no set-aside designation. The delivery order falls under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $24,552.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price delivery order was issued on a non-competitive, non-set-aside basis and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's larger Indefinite Delivery...
- SPE2DX22D0039Indefinite Delivery Contract
- SPE2DX22D0039-SPE2D826F0DP5Delivery Order
Amerisourcebergen Drug Corp (through its parent company Cencora, Inc.) received a delivery order award valued at $38,929.80 from the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Under this delivery order, Amerisourcebergen Drug Corp supplies pharmaceutical products and medical supplies to support federal military healthcare programs. The company's extensive IDC vehicle enables delivery of a comprehensive range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to serve the Defense Health Agency and other government healthcare systems. The non-set-aside award reflects the contractor's demonstrated capability to compete successfully in the open federal pharmaceutical procurement marketplace.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.9k | 1/5/26 |